Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Drug-resistant tuberculosis: a new shot on goal

Nature Medicine volume 20, pages 121–123 (2014)Cite this article

Subjects

Modification of a natural product with antibiotic properties to block its efflux from Mycobacterium tuberculosis results in a new drug candidate for tuberculosis with a promising therapeutic profile in mice (pages 152–158).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Mtb is susceptible to semisynthetic spectinamides but not to spectinomycin, the natural product from which spectinamides are derived.

Marina Corral Spence

References

  1. Nathan, C. Sci. Transl. Med. 4, 140sr2 (2012).

    Article  Google Scholar 

  2. Nathan, C. Nature 431, 899–902 (2004).

    Article  CAS  Google Scholar 

  3. Lee, R.E. et al. Nat. Med. 20, 152–158 (2014).

    Article  CAS  Google Scholar 

  4. Spellberg, B., Bartlett, J.G. & Gilbert, D.N. N. Engl. J. Med. 368, 299–302 (2013).

    Article  CAS  Google Scholar 

  5. Bolan, G.A., Sparling, P.F. & Wasserheit, J.N. N. Engl. J. Med. 366, 485–487 (2012).

    Article  Google Scholar 

  6. Raviglione, M. et al. Lancet 379, 1902–1913 (2012).

    Article  Google Scholar 

  7. Ahuja, S.D. et al. PLoS Med. 9, e1001300 (2012).

    Article  CAS  Google Scholar 

  8. Tiemersma, E.W., van der Werf, M.J., Borgdorff, M.W., Williams, B.G. & Nagelkerke, N.J. PLoS ONE 6, e17601 (2011).

    Article  CAS  Google Scholar 

  9. Avorn, J. J. Am. Med. Assoc. 309, 1349–1350 (2013).

    Article  CAS  Google Scholar 

  10. Chakraborty, S., Gruber, T., Barry, C.E. III, Boshoff, H.I. & Rhee, K.Y. Science 339, 88–91 (2013).

    Article  CAS  Google Scholar 

  11. Prideaux, B. et al. Anal. Chem. 83, 2112–2118 (2011).

    Article  CAS  Google Scholar 

  12. Mukamolova, G.V., Turapov, O., Malkin, J., Woltmann, G. & Barer, M.R. Am. J. Respir. Crit. Care Med. 181, 174–180 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Carl Nathan is at the Department of Microbiology and Immunology, Weill Cornell Medical College, and the Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences of Cornell University, New York, New York, USA.,

    Carl Nathan

Authors
  1. Carl Nathan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carl Nathan.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nathan, C. Drug-resistant tuberculosis: a new shot on goal. Nat Med 20, 121–123 (2014). https://doi.org/10.1038/nm.3470

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3470

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing